Key facts
- This page summarizes Arjun Goyal's Form 4 filing for Centessa Pharmaceuticals plc (CNTA).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Jul 2022, 19:00.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
The shares subject to such option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to continued service as a director through the applicable vesting date.
Footnote F2
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.